PLx Pharma
PLx Pharma Inc. — Creator of PL2200 Aspirin and PL1100 Ibuprofen.
Launch date
Employees
Market cap
€2.3m
Enterprise valuation
(€7m) (Public information from Apr 2023)
Share price
$0.004 PLXP
Houston Texas (HQ)
Financials
Estimates*
USD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Revenues | - | - | - | - | 9.0m | 32.0m |
% growth | - | - | - | - | - | 256 % |
EBITDA | - | (11.0m) | (15.0m) | (26.0m) | - | - |
Profit | (15.0m) | - | (34.0m) | (16.0m) | (48.0m) | (41.0m) |
% profit margin | - | - | - | - | (533 %) | (128 %) |
EV / revenue | - | - | - | - | 16.2x | 4.6x |
EV / EBITDA | - | -1.2x | -2.7x | -2.9x | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $3.1m | Early VC | |
N/A | $2.0m | Early VC | |
$2.9m | Early VC | ||
$8.3m | Early VC | ||
N/A | $9.0m | Early VC | |
N/A | N/A | IPO | |
N/A | $1.3m | Debt | |
N/A | Debt | ||
N/A | $63.0m | Post IPO Equity | |
N/A | N/A | Bankruptcy | |
Total Funding | €23.0m |
Recent News about PLx Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by PLx Pharma
EditACQUISITION by PLx Pharma Dec 2016